JP2009539938A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539938A5
JP2009539938A5 JP2009514801A JP2009514801A JP2009539938A5 JP 2009539938 A5 JP2009539938 A5 JP 2009539938A5 JP 2009514801 A JP2009514801 A JP 2009514801A JP 2009514801 A JP2009514801 A JP 2009514801A JP 2009539938 A5 JP2009539938 A5 JP 2009539938A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
piperidinecarboxamide
piperazinyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514801A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539938A (ja
JP5232143B2 (ja
Filing date
Publication date
Priority claimed from GBGB0611907.7A external-priority patent/GB0611907D0/en
Application filed filed Critical
Publication of JP2009539938A publication Critical patent/JP2009539938A/ja
Publication of JP2009539938A5 publication Critical patent/JP2009539938A5/ja
Application granted granted Critical
Publication of JP5232143B2 publication Critical patent/JP5232143B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514801A 2006-06-15 2007-06-14 モチリン受容体アンタゴニストとしてのベンジルピペラジン誘導体 Expired - Fee Related JP5232143B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0611907.7A GB0611907D0 (en) 2006-06-15 2006-06-15 Compounds
GB0611907.7 2006-06-15
PCT/EP2007/055890 WO2007144400A1 (en) 2006-06-15 2007-06-14 Benzylpiperazine derivatives as motilin receptor antagonists

Publications (3)

Publication Number Publication Date
JP2009539938A JP2009539938A (ja) 2009-11-19
JP2009539938A5 true JP2009539938A5 (cg-RX-API-DMAC7.html) 2013-03-21
JP5232143B2 JP5232143B2 (ja) 2013-07-10

Family

ID=36775731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514801A Expired - Fee Related JP5232143B2 (ja) 2006-06-15 2007-06-14 モチリン受容体アンタゴニストとしてのベンジルピペラジン誘導体

Country Status (7)

Country Link
US (2) US8012981B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029538B1 (cg-RX-API-DMAC7.html)
JP (1) JP5232143B2 (cg-RX-API-DMAC7.html)
AT (1) ATE542795T1 (cg-RX-API-DMAC7.html)
ES (1) ES2379658T3 (cg-RX-API-DMAC7.html)
GB (1) GB0611907D0 (cg-RX-API-DMAC7.html)
WO (1) WO2007144400A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0611907D0 (en) * 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
JO2747B1 (en) 2005-07-26 2014-03-15 جلاكسو جروب ليمتد Vehicles
GB0524814D0 (en) * 2005-12-05 2006-01-11 Glaxo Group Ltd Compounds
PL2041093T3 (pl) 2006-06-28 2010-09-30 Glaxo Group Ltd Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38
JP2011508352A (ja) 2007-12-28 2011-03-10 サーバー テクノロジー インコーポレイテッド 電源の分配、管理、及び監視システム並びに方法
EP2404354B1 (en) 2009-03-04 2018-11-07 Server Technology, Inc. Monitoring power-related parameters in a power distribution unit
US9452980B2 (en) * 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CN105640964A (zh) 2010-04-21 2016-06-08 文蒂雷克斯药品公司 增强抗体依赖性细胞的细胞毒性的方法
CN103108866B (zh) 2010-09-27 2015-09-09 第一三共株式会社 环己烷衍生物化合物
US9566347B2 (en) 2011-02-07 2017-02-14 The Trustees Of The University Of Pennsylvania Peptides and methods using same
RS60825B1 (sr) 2016-03-17 2020-10-30 Hoffmann La Roche Aktivnost derivata 5-etiol-4-metil-pirazol-3-karboksamida kao agonista taar-a

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385912A (en) 1991-03-08 1995-01-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. Multicyclic tertiary amine polyaromatic squalene synthase inhibitors
WO1992015579A1 (en) 1991-03-08 1992-09-17 Rhone-Poulenc Rorer International (Holdings) Inc. Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors
JPH06211886A (ja) 1992-11-04 1994-08-02 Chugai Pharmaceut Co Ltd エリスロマイシン誘導体
TW355711B (en) 1992-11-04 1999-04-11 Chugai Pharmaceutical Co Ltd Erythromycin derivatives
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
JP3901239B2 (ja) 1996-03-13 2007-04-04 大正製薬株式会社 アリールアルカン誘導体
WO1997036605A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5965578A (en) 1996-04-03 1999-10-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
DE19644195A1 (de) 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6100239A (en) 1996-11-26 2000-08-08 Chugai Seiyaku Kabushiki Kaisha 13-membered ring macrolide compound, medicine containing the same, and process for producing the same
US6060491A (en) 1997-06-19 2000-05-09 Dupont Pharmaceuticals 6-membered aromatics as factor Xa inhibitors
US5972939A (en) 1997-10-28 1999-10-26 Ortho-Mcneil Pharmaceutical, Inc. Cyclopentene derivatives useful as antagonists of the motilin receptor
DE19805822B4 (de) 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6165985A (en) 1998-02-13 2000-12-26 Solvay Pharmaceuticals Gmbh 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them
GB9804734D0 (en) 1998-03-05 1998-04-29 Pfizer Ltd Compounds
US20020010184A1 (en) 2000-02-18 2002-01-24 Dinsmore Christopher J. Inhibitors of prenyl-protein transferase
US20020052380A1 (en) 2000-02-18 2002-05-02 Dinsmore Christopher J. Inhibitors of prenyl-protein transferase
WO2001068621A1 (en) 2000-03-13 2001-09-20 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclohexene derivatives useful as antagonists of the motilin receptor
WO2001068622A1 (en) 2000-03-13 2001-09-20 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclobutene derivatives useful as antagonists of the motilin receptor
WO2001068620A1 (en) 2000-03-13 2001-09-20 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclopentene derivatives useful as antagonists of the motilin receptor
US6511980B2 (en) * 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
JP2004529184A (ja) * 2001-05-10 2004-09-24 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規1−アミドメチルカルボニル−ピペリジン誘導体、該誘導体を製造するための方法及び中間体並びにこれらの化合物を含有している医薬
US6977264B2 (en) 2001-07-25 2005-12-20 Amgen Inc. Substituted piperidines and methods of use
US7279491B2 (en) * 2002-10-23 2007-10-09 Janssen Pharmaceutica N.V. Phenylpiperidines and phenylpyrrolidines
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
US7338954B2 (en) 2003-09-17 2008-03-04 Bristol-Myers Squibb Company Compounds useful as motilin agonists and method
US7262195B2 (en) 2003-09-17 2007-08-28 Bristol-Myers Squibb Company Compounds useful as motilin agonists and method
WO2005063720A1 (ja) 2003-12-25 2005-07-14 Nippon Shinyaku Co., Ltd. アミド誘導体及び医薬
WO2005077373A2 (en) 2004-02-03 2005-08-25 Astrazeneca Ab Treatment of gastro-esophageal reflux disease (gerd)
WO2005077368A2 (en) 2004-02-03 2005-08-25 Astrazeneca Ab Treatment of gastro-esophageal reflux disease (gerd)
WO2005077345A1 (en) 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
WO2005089515A2 (en) 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
CA2559285A1 (en) 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20070293539A1 (en) 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
CA2559221A1 (en) 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20050288298A1 (en) 2004-03-18 2005-12-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
SE0401345D0 (sv) 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
SE0401970D0 (sv) 2004-08-02 2004-08-02 Astrazeneca Ab Novel compounds
GB0611907D0 (en) * 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
WO2007007018A1 (en) 2005-07-12 2007-01-18 Glaxo Group Limited Piperazine heteroaryl derivates as gpr38 agonists
JO2747B1 (en) 2005-07-26 2014-03-15 جلاكسو جروب ليمتد Vehicles
GB0524814D0 (en) 2005-12-05 2006-01-11 Glaxo Group Ltd Compounds
PL2041093T3 (pl) 2006-06-28 2010-09-30 Glaxo Group Ltd Pochodne piperazynylowe użyteczne w leczeniu zaburzeń, którym pośredniczy receptor GPR38
GB0723317D0 (en) 2007-11-28 2008-01-09 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
JP2008519814A5 (cg-RX-API-DMAC7.html)
US6784192B2 (en) Piperidine compound and pharmaceutical composition thereof
RU2489148C2 (ru) Ингибитор активации stat3/5
HUP0103988A2 (en) New d3-dopamine receptor selective piperazine and piperidine compounds, process for their preparation, their and pharmaceutical compositions containing them
JP2010538076A5 (cg-RX-API-DMAC7.html)
RU2004119406A (ru) 5-сульфанил-4н-1,2,4-триазольные производные и их применение в качестве лекарственного препарата
JP2004518725A5 (cg-RX-API-DMAC7.html)
KR970703333A (ko) 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists)
JP2015517981A5 (cg-RX-API-DMAC7.html)
RU2007139453A (ru) Гетеробициклические ингибиторы вируса гепатита с (hcv)
RU2010116765A (ru) Никотинамидные производные, их получение и их применение в терапии
JP2005513123A5 (cg-RX-API-DMAC7.html)
CA2476343A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
EP0661266A1 (en) Substituted cyclic amine compounds as 5HT2 antagonists
JP2010504930A5 (cg-RX-API-DMAC7.html)
HRP20100284T1 (hr) Derivati piperazinila korisni u liječenju bolesti posredovanih receptorom gpr38
JP2007231005A5 (cg-RX-API-DMAC7.html)
WO2000009483A3 (en) Process and intermediates for production of donepezil and related compounds
HRP20151336T1 (hr) Tetrahidroizokinolin-1-on derivat ili njegova sol
RU98117621A (ru) Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт
EP0385043A1 (en) New derivatives of 4-substituted piperazines
CA2461963C (en) Cyclic amine compounds
JP2009520791A5 (cg-RX-API-DMAC7.html)
JP2010539155A5 (cg-RX-API-DMAC7.html)
US6498169B1 (en) Cyclic amine compounds and pharmaceutical composition containing the same